All Type of News
Ranks of top 10 drug makers radically to be reshuffled
After the mid 1990s the rank of the top 10 drug makers has shown a radical change. The ethical oriented companies kept growing up because of substantial declines in OTC markets.
Daewoo Security Company analysed the...
MOHW price policy on drugs and medical reimbursement proceeded correlatively.
In the parliamentary inspection of the government administration on Sept. 29 the MOHW clarified that the price policy of drugs and medical reimbursement payment should be proceeded at the same time as a package. The f...
Unfair trade acts including allowances and rebates to be prosecuted.
In connection with the upcoming implementation of actual purchasing price reimbursement system the MOHW plans to prepare special measures including prosecution to the National Tax Service (NTS) and the Public Prosecut...
Development of intermediary compounds for 4th generation antibiotics in progress.
Daewoong Chemical (President: Mr. Moon Soon-ku) has succeeded in developing the key intermediary compounds (DW-1150) for the new 4th generation of Phenem and Carbaphenem antibiotics,
The core technology of the i...
Fair trade order in insurance drug markets faced serious dilemma
The movement for keeping a fair trade order of insurance drugs having promoted by the KPMA encountered with serious conflicts. The Trade Order Commission of KPMA has placed a strict campaign for inciting drug makers n...
MOHW opposed against trial of medical/pharmacy separation model.
For the questions raised by Mr. Hwang Sung-kyun and Mr. Chung Ui-wha, the National Assembly members regarding possibility of trial for the medical and pharmacy separation system model or a stepwise implementation of t...
Lawmakers inspection of government administration focused on medical/pharmacy separation plan.
Both ruling and opposition lawmakers of the Health and Welfare Commission, the National Assembly made intensive interpellations on Sept. 20 over the current issues and demanded preparatory measures for the medical and...
Revised working rules of pharmaceutical affairs law to effect from Oct. 1
The MOHW promulgated the revised new working rules of the pharmaceutical affairs law on Oct. l, some major changes of which are as follows:
-So far the government has restricted authorization of manufacturing or im...
MOHW announced previously revised bill of pharmaceutical affairs law.
The MOHW drafted the revised bill of the pharmaceutical affairs law based on the final determination having made during the 2nd meeting of the Separation Execution Commission on Sept. 27 and took its previous announce...
Government price reduction plan of insurance drugs put off till Nov.
(Urgent)
The government plan for insurance drug price down as originally scheduled to implement from Oct. was postponed to Nov. 1 due to dispute unsettlement raised by civil consumer protection groups.
The MOHW ...
